New hope for young adults with stubborn obesity: drug boosts weight loss
Disease control
Completed
This study tested whether adding the drug semaglutide to lifestyle counseling helps young adults (ages 18-28) with obesity who previously did not lose enough weight through diet and exercise alone. About 246 participants were split into groups based on their past response to life…
Phase: PHASE4 • Sponsor: Signe Torekov • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC